Futures rise in quiet premarket 📈

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Tuesday, July 11th. I hope you have a great day in the market. Let's get ready to trade! Markets 📈 Stocks recovered from mid-day declines to close Monday's session higher. The Dow added 0.6%, while the S&P 500 gained 0.2%. The Nasdaq added 0.1%, while the small-cap Russell 2K rallied for a 1.6% gain. Futures are trending higher in early trading. S&P 500 contracts are up 0.1%. Sponsored [A Real "Ground Floor" Opportunity]( This company could be poised to disrupt a $208 billion industry, and you have an opportunity to snatch up shares for cheap. Better yet, this could be the one of the best times to get in you. Early movers could see enormous upside if this stock lives up to its potential. [Find Out How You Can Snatch Up this Stock Now]( Premarket Highlights 🔎 ⚪ None It's a quiet premarket. Traders are looking forward to tomorrow's CPI report, but markets appear to be holding relatively steady in the meantime. What to Watch Today 👀 Earnings Markets are returning to business-as-usual this week after the Fourth of July holiday. We'll get several earnings reports today, and there's more to come later in the week. These upcoming reports could be key catalysts to watch this week. Major Earnings 💰 None Economy 🏗 None Running Hot 🔥 Gainers - Trinity Place [TPHS] >> +10.9% - Acumen Pharma [ABOS] >> +22.7% - Akanda [AKAN] >> +9.1% - Wavedancer [WAVD] >> +12.9% Decliners - Viridian Therapeutics [VRDN] >> (18.8%) - VOXX [VOXX] >> (14.1%) - DSS [DSS] >> (16.8%) - Iovance Biotherapeutics [IOVA] >> (10.9%) CytoMed Therapeutics [GDTC] - Last Close: $3.49 CytoMed has been on a tear as of late. Last Thursday, the biotech firm was granted a U.S. patent for its licensed CAR-gamma Delta T Cell Technology. Since the news broke, shares have been marching steadily higher, and GDTC is seeing more big gains in today's premarket. GDTC is up 169.0% in today's premarket on elevated trading volume, despite no new announcements from the company. My Take: I don't think this patent totally explains this sudden move in GDTC, but I don't have anything else to go on at the moment. This firm is based in Singapore, so it's possible there was some international news that's slipping under U.S. investors' radar at the moment. Better Therapeutics [BTTX] - Last Close: $0.90 A new regulatory green light is boosting shares of Better Therapeutics. After Monday's close, the MedTech firm said the FDA authorized its AspyreRx digital therapeutic for adult patients with Type 2 diabetes. Better Therapeutics said it expects to launch the product commercially in Q4 in light of the FDA's decision. News of the approval sparked sent shares of BTTX soaring in Monday's after-market, and the stock is currently showing a 35.5% gain on elevated volume. My Take: BTTX fell 19.6% on Monday, so this news came at a good time for the company. It appears to have strong support at $0.63 per share, so there could be upside ahead if it can keep the momentum rolling. Adial Pharma [ADIL] - Last Close: $0.2023 Adial Pharma investors are enjoying a much-needed rebound rally. The company's shares are rallying after Nasdaq granted its request to extend the deadline to file its quarterly report until Aug. 21st, 2023. Adial Pharma will be expected to publish financial results for the quarter ended June 30th by the deadline to avoid penalties. The company also expects the quarterly report to include a plan to regain compliance with Nasdaq's minimum shareholder equity rules. ADIL is up 23.5% on the news. My Take: ADIL looks like it's in bad shape. There could be more opportunities for short-term pops in share prices in the weeks ahead, but I am bearish. Crown Electrokinetics [CRKN] - Last Close: $0.102 Crown Electrokinetics is making big waves in today's premarket. The high-tech materials firm published a Form 424B4 on Monday relating to an upcoming offering from certain selling shareholders. Shares CRKN fell 13.5% on Monday following the report's release, but the stock is rebounding in today's premarket. CRKN is up 27.3% ahead of today's open, and it's the premarket's most actively traded stock. My Take: CRKN's sudden reversal could be a sign that the stock is approaching its bottom. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](